Summary SciGen Ltd (SciGen), a subsidiary of Bioton SA is a biotechnology company that manufactures, develops, and markets recombinant human health care biotechnology derived products. The company’s products include second generation recombinant human insulin, recombinant human growth hormone and silicone gel. It also provides recombinant human granulocyte-colony stimulating factor, and adjunctive anti-epileptic drug, among others. SciGen’ products are used in the areas of gastroenterology,...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.